Hadassah

Hadassah Hospital’s Bone Marrow Transplant Department Receives International Acclaim

Wednesday, Aug 15 2018

Dr.Polina Stepensky

In a first for Israel, Hadassah Medical Organization’s Bone Marrow Transplantation and Cancer Immunotherapy Department has recently received full accreditation by the Joint Accreditation Committee ISCT-EUROPE & EBMT (JACIE), Europe’s only official accreditation body in the field.

JACIE inspectors, who spent a month at Hadassah Hospital Ein Kerem to inspect the department, included European bone marrow transplant experts and top department heads from the University Hospital of Basel in Switzerland and from the university hospitals in Bristol and London in the United Kingdom. They reviewed all areas of activity in Hadassah’s department, including the daily work, exacting protocols, and infrastructure for complex procedures conducted in the department. Hadassah is the first of the large departments in Israel to receive accreditation for the clinical side as well.

JACIE inspectors expressed their satisfaction and admiration for the high quality of the department, as follows:

• The department’s medical, clinical, nursing, and quality-assurance procedures; laboratory procedures for collection and processing; and transplant coordination procedures were all written meticulously and professionally, and, most importantly, implemented exactly.

• The medical and nursing staff, the laboratory teams, and the transplant coordinators all demonstrated knowledge, professionalism, and dedication. Particular mention was made of the cooperation, the pride of the department, and the positive and supportive atmosphere within the teams.

• Dr. Sigal Grisaru, Quality Manager of the department, and Yevgeny Frank-Kamenetsky, the department's head nurse, received a commendation for the quality and safety of all areas related to bone marrow transplants and cellular therapy.

• Department Director Prof. Polina Stepensky, who assumed the position at the beginning of 2017, was commended for leading the team to achieve high-quality transplants, patient treatments, and advancing clinical and basic research. 

 “This accreditation places Hadassah’s department in line with the best transplant centers in the world and will enable the introduction of advanced cellular therapies for complex patients who currently are not able to receive treatment in Israel,” said Prof. Stepensky.

 “Preparing the department for accreditation was a complex process that requires knowledge in the areas of regulation, forming protocols, and quality programming,” said Prof. Stepensky. “For this purpose, we relied on the services of the GSAP consulting firm, which specializes in the process of regulation, clinics, quality, and validation in Israel and throughout the world.”  

This accreditation demonstrates excellence in the quality of patient care for these complicated medical cases. In 2017 Hadassah completed a record amount of transplants with outstanding results by any standard.

Prof. Zeev Rotstein, Director General of Hadassah Medical Organization, said, "The bone marrow transplantation department at Hadassah is considered one of the leading departments in Israel and abroad. Experts from all over the world consult with Prof. Stepensky when treating complex patients and make life-saving decisions with her. Now, the department's abilities and professionalism received accreditation from the official world body, whose representatives did not hide how impressed they were with the department. This is the excellence that we strive toward in every department at Hadassah.”

Learn more about the Hadassah Medical Organization.

Related Stories

alt_text

Wednesday, Apr 8 2020

Hadassah to Launch Clinical Trials of a Serum to Fight COVID-19

For the first time in Israel, Hadassah Hospital Ein Kerem is collecting plasma from recovered COVID-19 patients...

READ MORE ›
alt_text

Tuesday, Apr 7 2020

Virtual Community Gathering: Israel's Response to the Coronavirus

Israel's experts talk about the Coronavirus, how Israel responded and "best practices" developed via a Zoom panel discussion which included Hadassah Prof. Ran Nir-Paz, Infectious DIsease Physician.

READ MORE ›
alt_text

Tuesday, Apr 7 2020

Hadassah to Initiate Trials of Japanese Drug to Fight COVID-19 READ MORE ›
alt_text

Monday, Apr 6 2020

Hadassah Cardiologist: Don’t Let Fear of COVID-19 Keep You From Urgent Care

The advice to "stay home" should not be heeded if you have chest pains or other signs of a heart attack, warns Hadassah...

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Israel Travel

israeltravel@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More